PULMONARY THROMBOSIS

This adverse event was reported 10914 times

These drugs are most commonly taken by patients reporting PULMONARY THROMBOSIS:

# Drug Count
0 LENALIDOMIDE 1103
1 ADALIMUMAB 1072
2 RIVAROXABAN 604
3 PREDNISONE 576
4 ASPIRIN 508
5 METHOTREXATE SODIUM 496
6 ASPIRIN 325 MG 482
7 ASPIRIN 81 MG 482
8 METHOTREXATE 464
9 APIXABAN 454
See all common drugs associated with PULMONARY THROMBOSIS

PULMONARY THROMBOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GOLD 144 0.0248
1 CANAKINUMAB 211 0.0193
2 MINOCYCLINE HYDROCHLORIDE 88 0.0148
3 ANAKINRA 215 0.0127
4 ISRADIPINE 4 0.0071
5 MINOCYCLINE 83 0.0071
6 APIXABAN 454 0.0067
7 FOSFOMYCIN TROMETHAMINE 4 0.0065
8 RIOCIGUAT 180 0.0055
9 DALTEPARIN SODIUM 55 0.0052
See all drugs enriched for association with PULMONARY THROMBOSIS

PULMONARY THROMBOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 215 0.0127
1 Protease Activator [EPC] 1 0.0078
2 Soluble Guanylate Cyclase Stimulator [EPC] 180 0.0053
3 Factor Xa Inhibitor [EPC] 1051 0.0038
4 Human Immunoglobulin G [EPC] 61 0.0029
5 Aminosalicylate [EPC] 281 0.0028
6 Janus Kinase Inhibitor [EPC] 432 0.0027
7 Antirheumatic Agent [EPC] 276 0.0026
8 Thalidomide Analog [EPC] 1281 0.0025
9 Interleukin-6 Receptor Antagonist [EPC] 322 0.0023
See all drug classes enriched for association with PULMONARY THROMBOSIS